Neutralizing Anti-Rituximab Antibodies and Relapse in Membranous Nephropathy Treated With Rituximab

Membranous Nephropathy (MN) is an autoimmune disease associated with antibodies against podocyte proteins: M-type phospholipase A2 receptor (PLA2R1) or thrombospondin type-1 domain-containing 7A (THSD7A) in 70 and 3% of patients, respectively. Antibody titer is correlated with disease activity: risi...

Descripción completa

Detalles Bibliográficos
Autores principales: Boyer-Suavet, Sonia, Andreani, Marine, Lateb, Maël, Savenkoff, Benjamin, Brglez, Vesna, Benzaken, Sylvia, Bernard, Ghislaine, Nachman, Patrick H., Esnault, Vincent, Seitz-Polski, Barbara
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6970431/
https://www.ncbi.nlm.nih.gov/pubmed/31998325
http://dx.doi.org/10.3389/fimmu.2019.03069

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6970431/
https://www.ncbi.nlm.nih.gov/pubmed/31998325
http://dx.doi.org/10.3389/fimmu.2019.03069

Ejemplares similares